This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
NAROPIN
ASPEN PHARMACARE CANADA INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is NAROPIN discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that NAROPIN 2MG has been permanently discontinued (last updated July 22, 2025). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is NAROPIN not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02229411
Strength
2MG
Dosage Form
SOLUTION
Route
EPIDURAL BLOCK/INFILTRATION
Active Ingredient
ROPIVACAINE HYDROCHLORIDE
Tier
Unrated
Last Updated
2022-06-24
Reason for Shortage
Delay in shipping of the drug.
Past Reports for This Drug
NAROPIN has 4 shortage/discontinuation reports on file — this is one of them.
Other Products from ASPEN PHARMACARE CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
2MG · DIN 00004715
DIN 02087286
2.5MG · DIN 02245531
7.5MG · DIN 02258056
2MG · DIN 02493055
10MG · DIN 02018950
300MCG · DIN 02213230
150MCG · DIN 02213214
200MCG · DIN 02213222
50MCG · DIN 02213192
100MCG · DIN 02213206
DIN 00886858